DESTINA & SMCxPro featuring at Biomarker Series UK Conference in Manchester

On 20th February 2020 at 9:30am GMT, Hugh Ilyine will present, during the New Biomarker Technologies & Data Session, the integration of DESTINA Chemistry within Merck SMCxPro platform for quantifying miRNA molecules directly from body fluids. The title of his talk is Novel Single Molecule Counting (SMC) Of MicroRNA By A PCR Free Method. See…